Stay updated on Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page
- ChecktodayChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is no longer enrolling. Additional changes include adding user-help sections (How to Read a Study Record, Common Questions, How to Join a Study), standardizing the Intervention header to 'Intervention/Treatment', and updating the page revision to v3.6.0.SummaryDifference0.4%

- Check8 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This indicates a minor update to the page's documentation or version history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small software or content-management update to the page.SummaryDifference0.1%

- Check43 days agoChange DetectedFooter now shows Revision: v3.5.3, replacing v3.5.2, indicating a software version update. This change does not affect trial data, eligibility criteria, or page content.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded Hepatocellular carcinoma as a disease tag and a new Genetic and Rare Diseases Information Center resource link. Updated page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.